16
Participants
Start Date
February 1, 2020
Primary Completion Date
January 1, 2021
Study Completion Date
April 1, 2021
Lactobacillus plantarum ECGC 13110402
The study will consist of two phases: a treatment period (12 weeks) with either the active or placebo and a wash-out period (4 weeks). Following a screening visit to ensure adherence to the inclusion criteria, the study will consist of a baseline, midpoint, endpoint (week 6 and 12, respectively) and washout visit (week 16).
Placebo Comparator: Maltodextrin
Please see intervention description above.
Health Sciences Research Centre, Life Sciences Department, University of Roehampton, London
University of Roehampton
OTHER